These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 26658934)

  • 1. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice.
    Schapira MM; Sprague BL; Klabunde CN; Tosteson AN; Bitton A; Chen JS; Beaber EF; Onega T; MacLean CD; Harris K; Howe K; Pearson L; Feldman S; Brawarsky P; Haas JS;
    J Gen Intern Med; 2016 Oct; 31(10):1148-55. PubMed ID: 27251058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Kolade VO; Meseeha MG
    J Gen Intern Med; 2016 Apr; 31(4):411. PubMed ID: 26857730
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.
    McCarthy AM; Kim JJ; Beaber EF; Zheng Y; Burnett-Hartman A; Chubak J; Ghai NR; McLerran D; Breen N; Conant EF; Geller BM; Green BB; Klabunde CN; Inrig S; Skinner CS; Quinn VP; Haas JS; Schnall M; Rutter CM; Barlow WE; Corley DA; Armstrong K; Doubeni CA;
    Am J Prev Med; 2016 Oct; 51(4):507-12. PubMed ID: 27132628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening.
    Beaber EF; Kim JJ; Schapira MM; Tosteson AN; Zauber AG; Geiger AM; Kamineni A; Weaver DL; Tiro JA;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv120. PubMed ID: 25957378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.
    Haas JS; Sprague BL; Klabunde CN; Tosteson AN; Chen JS; Bitton A; Beaber EF; Onega T; Kim JJ; MacLean CD; Harris K; Yamartino P; Howe K; Pearson L; Feldman S; Brawarsky P; Schapira MM;
    J Gen Intern Med; 2016 Jan; 31(1):52-9. PubMed ID: 26129780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.
    Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson ANA
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):158-164. PubMed ID: 29150480
    [No Abstract]   [Full Text] [Related]  

  • 10. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
    Onega T; Garcia M; Beaber EF; Haas JS; Breslau ES; Tosteson ANA; Halm E; Chao CR; Barlow WE
    J Gen Intern Med; 2024 Jun; 39(8):1324-1331. PubMed ID: 38097863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    Corley DA; Haas JS; Kobrin S
    JAMA; 2016 May; 315(19):2067-8. PubMed ID: 27089237
    [No Abstract]   [Full Text] [Related]  

  • 14. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
    Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
    Elife; 2022 Jun; 11():. PubMed ID: 35762572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
    Amboree TL; Montealegre JR; Parker SL; Garg A; Damgacioglu H; Schmeler KM; Chiao EY; Hill EG; Sonawane K; Deshmukh AA; Adsul P
    JAMA Intern Med; 2024 Jun; 184(6):671-679. PubMed ID: 38683574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and provider characteristics associated with colorectal, breast, and cervical cancer screening among Asian Americans.
    Thompson CA; Gomez SL; Chan A; Chan JK; McClellan SR; Chung S; Olson C; Nimbal V; Palaniappan LP
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2208-17. PubMed ID: 25368396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and Trends of Cancer Screening in Canada: Results From a Contemporary National Survey.
    Abdel-Rahman O
    J Natl Compr Canc Netw; 2021 Jan; 19(1):68-76. PubMed ID: 33406489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.